Source comparison
BPC-157 Research Flexibility: Administration Route Comparison
Subcutaneous Injection 200–500 µg/kg daily Slower absorption, localized tissue exposure, sustained effect over 8–12 hours Tendon/ligament healing, localized tissue repair, musculoskeletal injury models 2–8°C storage post-reconstitution, 28-day use window Low.
This comparison does not assign a generated winner or score.
- Subcutaneous Injection
- 200–500 µg/kg daily
- Slower absorption, localized tissue exposure, sustained effect over 8–12 hours
- Tendon/ligament healing, localized tissue repair, musculoskeletal injury models
- 2–8°C storage post-reconstitution, 28-day use window
- Low. Single-site injection, minimal restraint time
- Intraperitoneal Injection
- 10–50 µg/kg daily
- Rapid systemic distribution, higher peak plasma levels, shorter duration
- Gastric ulcer prevention, systemic inflammatory response, organ protection studies
- Moderate. Requires peritoneal access, slightly longer procedure
- Oral Gavage
- 500–1000 µg/kg daily
- Low systemic bioavailability, direct mucosal contact in GI tract
- Ulcer healing, intestinal barrier function, mucosal protection research
- 2–8°C storage post-reconstitution, 7-day use window (faster degradation in solution)
- High. Requires gavage skill, more stressful for subjects, higher dose needed